Shareholders Equity: The sum of preferred and common equity items.
Theralase Technologies Inc. (V.TLT) had Shareholders Equity of 0.81M for the most recently reported fiscal quarter, ending 2018-03-31.
| Income Statement Financials | |
-- |
|
-0.79M |
|
-- |
|
-- |
|
-- |
|
-0.79M |
|
-- |
|
-0.79M |
|
-0.79M |
|
-0.79M |
|
-0.79M |
|
-0.79M |
|
-0.79M |
|
-0.79M |
|
-0.75M |
|
125.38M |
|
125.38M |
|
-0.01 |
|
-0.01 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
2.26M |
|
-- |
|
-- |
|
-- |
|
1.46M |
|
0.81M |
|
0.78M |
|
|
Shareholders Equity |
0.81M |
126.48M |
|
| Cash Flow Statement Financials | |
-0.16M |
|
-0.02M |
|
-- |
|
0.20M |
|
0.02M |
|
-0.18M |
|
-0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
44.95% |
|
-227.24% |
|
-227.24% |
|
-- |
|
-227.58% |
|
-227.58% |
|
-0.18M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.26 |
|
0.42 |
|
215.80 |
|
-98.25% |
|
-101.37% |
|
-35.04% |
|
-98.25% |
|
0.01 |
|
-0.00 |
|
-0.00 |
|